login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
DSS INC (DSS) Stock News
USA
- NYSEARCA:DSS -
US26253C2017
-
Common Stock
1.38
USD
+0.03 (+2.22%)
Last: 10/17/2025, 8:07:15 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DSS Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Benzinga
- Mentions:
OMEX
OPTT
BTM
SES
...
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
a month ago - By: Benzinga
- Mentions:
NCL
TPC
POLA
BNC
...
12 Industrials Stocks Moving In Friday's After-Market Session
9 months ago - By: DSS, Inc.
DSS, Inc. Issues Letter to Shareholders
a year ago - By: InvestorPlace
DSS Stock Earnings: DSS Misses Revenue for Q2 2024
a year ago - By: InvestorPlace
DSS Stock Earnings: DSS Reported Results for Q1 2024
2 years ago - By: InvestorPlace
DSS Stock Earnings: DSS Reported Results for Q4 2023
4 months ago - By: DSS, Inc.
DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger
5 months ago - By: DSS, Inc.
DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth
8 months ago - By: DSS, Inc.
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
a year ago - By: DSS, Inc.
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
a year ago - By: DSS, Inc.
AmericaFirst Funds Trust Announces Changes to Board of Trustees
a year ago - By: DSS, Inc.
DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
2 years ago - By: InvestorPlace
- Mentions:
MULN
BETS
The $40 Million EV: How Mullen Lost $1 Billion… And Accidentally Produced the World’s Most Expensive Car
2 years ago - By: DSS, Inc.
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
2 years ago - By: Seeking Alpha
DSS chairman Chan acquires 672,173 shares in open market; shares jump (NYSE:DSS)
Please enable JavaScript to continue using this application.